Incidence trends and survival of metastatic prostate cancer with bone and visceral involvement: 2010-2019 surveillance, epidemiology, and end results

ABSTRACT:

Background

The incidence of prostate cancer (PCa) has continued to increase since the US Preventive Services Task Force (USPSTF) recommendations against prostate-specific antigen (PSA)-based screening for all men in 2012, approximately half of additional diagnosed cases are advanced-stage, including regional PCa and metastatic PCa (mPCa). It is very important to investigate the shift in mPCa incidence and mPCa-related mortality risk, as the survival of mPCa remains poor.

Objective

To investigate the incidence temporal trend of mPCa stratified by metastatic site, including bone and visceral metastatic involvement, and potential survival improvements.

Materials

Based on the recently released Surveillance, Epidemiology, and End Results (SEER) data (2010-2019), the a

SUBMITTER: Kadeerhan G 

PROVIDER: S-EPMC10435983 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature